Cargando…

Intensive Cytotoxic Chemotherapy

Detalles Bibliográficos
Autor principal:	Bagshawe, K. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of Physicians of London 1971
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366643/ https://www.ncbi.nlm.nih.gov/pubmed/4131399

Ejemplares similares

The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites.
por: Bagshawe, K. D.
Publicado: (1989)

Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumours.
por: Coppack, S., et al.
Publicado: (1983)

The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
por: Crawford, S. M., et al.
Publicado: (1989)

Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.
por: Smith, D. B., et al.
Publicado: (1990)

Chemotherapy of advanced malignant teratomas.
por: Newlands, E. S., et al.
Publicado: (1980)

A cytotoxic agent can be generated selectively at cancer sites.
por: Bagshawe, K. D., et al.
Publicado: (1988)

A cytotoxic DNA precursor is taken up selectively by human cancer xenografts.
por: Bagshawe, K. D., et al.
Publicado: (1987)

Doppler assessment of the uterine circulation and the clinical behaviour of gestational trophoblastic tumours requiring chemotherapy.
por: Long, M. G., et al.
Publicado: (1992)

Dose intensity in cancer chemotherapy.
por: Dodwell, D. J., et al.
Publicado: (1990)

Editorial
por: Bagshawe, K. D.
Publicado: (1984)

Tumour growth and anti-mitotic action. The role of spontaneous cell losses.
por: Bagshawe, K. D.
Publicado: (1968)

Proceedings: The value of hormone measurements in tumour management.
por: Bagshawe, K. D.
Publicado: (1974)

Antibody directed enzymes revive anti-cancer prodrugs concept.
por: Bagshawe, K. D.
Publicado: (1987)

Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here?
por: Bagshawe, K. D.
Publicado: (1983)

Cytotoxic Chemotherapy and Viral Infections: The Role of Acyclovir
por: Anderson, Heather, et al.
Publicado: (1984)

Recent Advances in Cancer Treatment, Vol. 3
por: Bagshawe, K. D.
Publicado: (1978)

An Atlas of Oncology
por: Bagshawe, K D
Publicado: (1995)

Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
por: Hitchins, R. N., et al.
Publicado: (1989)

Protecting normal cells from the cytotoxicity of chemotherapy
por: Cheok, Chit Fang
Publicado: (2012)

Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?
por: Rabinowits, Guilherme
Publicado: (2017)

Cytotoxic Chemotherapy Tooth Ache Following Chemotherapy: a Rare Case Report
por: Kuzekanani, Maryam, et al.
Publicado: (2012)

ORAL CONTRACEPTIVES AND POST-MOLAR TROPHOBLASTIC TUMOURS
por: Bagshawe, K.D., et al.
Publicado: (1980)

Different treatment efficacies and side effects of cytotoxic chemotherapy
por: Li, Low-Jia, et al.
Publicado: (2020)

Serum folate and FIGLU excretion in patients with trophoblastic tumours.
por: Hughes, M., et al.
Publicado: (1968)

Activity of high-dose cis-platinum (NCI 119875) in combination with vincristine and methotrexate in drug-resistant gestational choriocarcinoma. A report of 17 cases.
por: Newlands, E. S., et al.
Publicado: (1979)

Enhancement of human chorionic gonadotrophin production by antimetabolites.
por: Browne, P., et al.
Publicado: (1982)

Tumor mutational burden is not predictive of cytotoxic chemotherapy response
por: Nikanjam, Mina, et al.
Publicado: (2020)

Management of cytotoxic chemotherapy-induced hand-foot syndrome
por: Kwakman, Johannes J.M., et al.
Publicado: (2020)

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma
por: Cortinovis, Diego, et al.
Publicado: (2021)

Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times
por: Bailly, Christian, et al.
Publicado: (2020)

Time-of-Day Dictates Transcriptional Inflammatory Responses to Cytotoxic Chemotherapy
por: Borniger, Jeremy C., et al.
Publicado: (2017)

Collateral responses to classical cytotoxic chemotherapies are heterogeneous and sensitivities are sparse
por: Dalin, Simona, et al.
Publicado: (2022)

Anabolic Steroids and Bone Marrow Toxicity During Therapy with Methotrexate
por: Rawbone, R. G., et al.
Publicado: (1972)

Cellular Reaction in Trophoblastic Tumours
por: Elston, C. W., et al.
Publicado: (1973)

International symposium on gestational trophoblastic tumours: 23, 24 May 1979, Charing Cross Hospital, London
por: Newlands, E. S., et al.
Publicado: (1980)

Hospice management of patients receiving cytotoxic chemotherapy: problems and opportunities.
por: Hicks, F., et al.
Publicado: (1993)

Recovery of Spermatogenesis Following Cancer Treatment with Cytotoxic Chemotherapy and Radiotherapy
por: Okada, Keisuke, et al.
Publicado: (2019)

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer
por: Nara, Katsuhiko, et al.
Publicado: (2023)

Antagonism between inhibitors of DNA synthesis.
por: Bagshawe, K. D., et al.
Publicado: (1972)

Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
por: Currie, G. A., et al.
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_t5hq39uh5s08kdun90po3kkj18